Cytosorbents Corporation (CTSO)

Cytosorbents Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	45	49	68	182	344	125
Market Cap Growth	-64.95%	-27.07%	-62.87%	-47.06%	175.66%	-51.19%
Enterprise Value	52	52	62	142	273	128
PE Ratio	-	-1.73	-2.06	-7.42	-43.91	-6.48
PS Ratio	1.22	1.36	1.95	4.22	8.39	5.00
PB Ratio	2.36	2.12	1.91	2.91	4.34	36.52
P/FCF Ratio	-2.20	-2.22	-1.97	-10.32	-54.43	-7.15
P/OCF Ratio	-2.21	-2.28	-2.40	-13.01	-61.30	-7.45
EV/Sales Ratio	1.41	1.42	1.79	3.28	6.66	5.14
EV/EBITDA Ratio	-2.25	-1.90	-1.88	-5.85	-38.48	-6.84
EV/EBIT Ratio	-2.08	-1.77	-1.82	-5.59	-35.20	-6.64
EV/FCF Ratio	-2.50	-2.33	-1.80	-8.02	-43.23	-7.35
Debt / Equity Ratio	0.91	0.77	0.51	0.21	0.01	4.59
Debt / EBITDA Ratio	-0.66	-0.66	-0.55	-0.55	-0.08	-0.84
Debt / FCF Ratio	-0.73	-0.81	-0.53	-0.75	-0.09	-0.90
Quick Ratio	1.26	1.49	3.04	4.26	7.54	1.68
Current Ratio	1.49	1.77	3.48	4.70	8.12	2.10
Asset Turnover	0.73	0.69	0.50	0.47	0.57	0.86
Interest Coverage	-278.69	-184.70	-	-	-6.46	-18.70
Return on Equity (ROE)	-129.90%	-120.20%	-73.90%	-34.50%	-15.30%	-209.90%
Return on Assets (ROA)	-55.00%	-54.10%	-46.90%	-26.50%	-10.90%	-66.70%
Return on Capital (ROIC)	-77.95%	-75.72%	-58.90%	-29.99%	-13.00%	-99.27%
Earnings Yield	-61.71%	-57.79%	-48.51%	-13.48%	-2.28%	-15.43%
FCF Yield	-52.55%	-44.99%	-50.75%	-9.69%	-1.84%	-13.98%
Buyback Yield / Dilution	-24.24%	-2.49%	-0.49%	-11.70%	-20.35%	-5.00%
Total Shareholder Return	-24.24%	-2.49%	-0.49%	-11.70%	-20.35%	-5.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).